Method of reducing neuronal damage using omega conotoxin peptide

Details Method of reducing neuronal damage using omega conotoxin peptide Method of reducing neuronal damage using omega conotoxin peptide

1990-08-02

1993-02-23

Cashion, Jr., Merrell C.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

514 13, 514 14, 514 15, 514 21, 530324, 530325, 530326, 530327, A61K 3702, C07K 706, C07K 708, C07K 710

Patent

active

051890208

ABSTRACT:
A partially purified omega conotoxin binding protein is disclosed. The protein, either in partially purified form or in a synaptosomal preparation, is useful in identifying compounds for use in reducing neuronal damage related to an ischemic condition, such as stroke, in a human patient.

REFERENCES:
patent: 4447356 (1984-05-01), Olivera et al.
patent: 4925664 (1991-05-01), Jackson et al.
patent: 4950739 (1990-08-01), Cherksey et al.
Hamilton et al., Report 1989-Govt. Rep. Announce. Index (US), vol. 89 (22) p. 173 entry #960328 (1989).
Govoni et al., Minerva Med. vol. 77 (24) pp. 1053-1058 (1986) (abstract).
Iida et al., Jpn. Heart 3, vol. 31 (4) p. 536 (1990).
Mossakowski et al. Neuropat. Pol., vol. 25 (4) pp. 439-450 (1987).
Shapira et al., Brain Res., vol. 523 (2) pp. 291-294 (1990).
Choi, D. W., "Calcium-mediated neurotoxicity: relationship to specific channel types and role in ischemic damage" TINS, vol. 11 (10) pp. 465-469 (1988).
Bean, B. P., Annu. Rev. Physiol. 51:367-384 (1989).
Greenberg, D. A., Curr. Neurol. 6:91-121 (1986).
Hossmann, K.-A, "Calcium antagonists for the treatment of brain ischemia: A critical appraisal".
Marqueze, Beatrice, et al., Molecular Pharmacology, 34:87-90 (1988).
Vibulsreth, S., et al., Stroke 18:210-216 (1987).
Ahmad, S., et al., Brain Research, 453:247-256 (1988).
Anderson, A. J., et al., Neuroscience Letts., 82:177-180 (1987).
Bennett, J. P. et al., Neutransmitter Receptor Binding, pp. 61-89 Raven Press, NY (1983).
Gray, W. R., et al., Ann. Rev. Biochem., 57, pp. 655-700 (1988).
Haley, T., et al., Brit. J. Pharmacol., 23, pp. 12-15 (1957).
Kirino, T., Brain Research, 239, pp. 57-69 (1982).
McCleskey, E. W., et al., PNAS, 84, pp. 4327-4331 (1987).
Olivera, B., et al., Science, 230, pp. 1338-1343 (1985).
Pulsinelli, W. A., et al., Stroke, 10, pp. 267-272 (1979).
Sano, K., et al., Eur. J. Pharmacol., 141, pp. 235-141 (1987).
Tsien, R. W., et al., TINS, 11, pp. 431-438 (1988).
Van Reempts, J., et al., Acad. Anaesthesiolica Belge, 35, Suppl., pp. 209-218 (1984).
Wauquier, A., et al., Neuroscience and Biobehaviorial Reviews, 11, pp. 287-306 (1987).
Yamaguchi, T., Klatzo, I., in Cerebral ishemia, (Bes, A., Braquet, P., and Sisejo, B. K., eds.), Elsevier Sciences Publ., pp. 13-24 (1984).
Yamashiro, D., Int. J. Protein Peptide Res., 30, pp. 9-12 (1987).
Alps, B. J., et al., Neurology, 37, pp. 809-815 (1987).
Cruz, L. J., et al., Biochemistry, 26, pp. 820-824 (1987).
Grotta, J. C., et al., Ann. Neurol., 27, pp. 612-619 (1990).
Jones, O. T., et al., Science, 244, pp. 1189-1193 (1989).
Olivera, B. M., et al., Biochemistry, 26, pp. 2086-2090 (1987).
Simon, R. P., et al., Science, 226, pp. 850-852 (1984).
Onodera, H., et al., Stroke, 21, pp. 771-776 (1990).

Affiliated with

Also associated with

Rating

Method of reducing neuronal damage using omega conotoxin peptide does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of reducing neuronal damage using omega conotoxin peptide, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of reducing neuronal damage using omega conotoxin peptide will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2204842